In one clinical trial [83]an intrathecal infusion of AAV-miR-SOD1 was administered to two patients suffering from familial amyotrophic lateral sclerosis (ALS) owing to mutations in the gene encoding superoxide dismutase 1 (SOD1). This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.